ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Fallout Study On Split Vote

March 13, 1981

In Brief: Greenwald Named Director, NCI Prevention; Wells Directs American College Of Surgeons

June 19, 1998

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.

July 28, 2006

Toxic Wastes And Cancer Linked; NCI Data Questioned In Bay Study

December 13, 1985